Common Contracts
10 similar Clinical Trial Agreement contracts
ContractClinical Trial Agreement • March 28th, 2024
INSTRUCTIONS [NTD: In case of Phase IV clinical trials, update references to “Investigational Product” for references to “Clinical Trial Product” here and below – see the wording highlighted in yellow] [NTD: See comments in green for single-site studies] [NTD: See comments in blue for Clinical trials involving the use of medical devices]
ContractClinical Trial Agreement • January 26th, 2023
INSTRUCTIONS [NTD: In case of Phase IV clinical trials, update references to “Investigational Product” for references to “Clinical Trial Product” here and below – see the wording highlighted in yellow] [NTD: See comments in green for single-site studies] [NTD: See comments in blue for Clinical trials involving the use of medical devices]
May 2017 MODEL CLINICAL TRIAL AGREEMENT FOR PHARMACEUTICAL INDUSTRY SPONSORED, PHASE [II or III] MULTI-SITE DRUG TRIALSClinical Trial Agreement • May 26th, 2022
Institution is an organisation engaged in the diagnosis, treatment and prevention of disease and/or clinical research for the improvement of healthcare, and has the facilities and Study Personnel necessary to conduct the Clinical Trial.
MODEL CLINICAL TRIAL AGREEMENTClinical Trial Agreement • January 6th, 2021
Clinical Trial Code: Clinical Trial Name: Final Protocol Date or Version or Investigational Product Number: Number of Clinical Trial Participants to be recruited for the Clinical Trial:
Jan 2021 MODEL CLINICAL TRIAL AGREEMENT FOR PHARMACEUTICAL INDUSTRY SPONSORED, PHASE [II or III] MULTI-SITE DRUG TRIALSClinical Trial Agreement • January 5th, 2021
Institution is an organisation engaged in the diagnosis, treatment and prevention of disease and/or clinical research for the improvement of healthcare, and has the facilities and Study Personnel necessary to conduct the Clinical Trial.
MODEL CLINICAL TRIAL AGREEMENTClinical Trial Agreement • February 4th, 2019
Clinical Trial Code: Clinical Trial Name: Final Protocol Date or Version or Investigational Product Number: Number of Clinical Trial Participants to be recruited for the Clinical Trial:
MODEL CLINICAL TRIAL AGREEMENTClinical Trial Agreement • August 4th, 2017
Clinical Trial Code: Clinical Trial Name: Final Protocol Date or Version or Investigational Product Number: Number of Clinical Trial Participants to be recruited for the Clinical Trial:
May 2017 MODEL CLINICAL TRIAL AGREEMENTClinical Trial Agreement • August 4th, 2017
Clinical Trial Code: Clinical Trial Name: Final Protocol Date or Version or Investigational Product Number: Number of Clinical Trial Participants to be recruited for the Clinical Trial:
May 2017 MODEL CLINICAL TRIAL AGREEMENT FOR PHARMACEUTICAL INDUSTRY SPONSORED, PHASE [II or III] MULTI-SITE DRUG TRIALSClinical Trial Agreement • May 18th, 2017
Institution is an organisation engaged in the diagnosis, treatment and prevention of disease and/or clinical research for the improvement of healthcare, and has the facilities and Study Personnel necessary to conduct the Clinical Trial.
May 2017 MODEL CLINICAL TRIAL AGREEMENT FOR PHARMACEUTICAL INDUSTRY SPONSORED, PHASE [II or III] MULTI-SITE DRUG TRIALSClinical Trial Agreement • May 18th, 2017
Institution is an organisation engaged in the diagnosis, treatment and prevention of disease and/or clinical research for the improvement of healthcare, and has the facilities and Study Personnel necessary to conduct the Clinical Trial.
